Iradimed (IRMD) Expected to Announce Earnings on Thursday

Iradimed (NASDAQ:IRMD) will likely be releasing its earnings data before the market opens on Thursday, February 13th. Analysts expect Iradimed to post earnings of $0.45 per share and revenue of $19.20 million for the quarter. Persons that are interested in registering for the company’s earnings conference call can do so using this link.

Iradimed Stock Performance

IRMD stock opened at $61.18 on Wednesday. The firm has a fifty day moving average price of $56.90 and a 200 day moving average price of $51.87. Iradimed has a fifty-two week low of $40.18 and a fifty-two week high of $63.29. The firm has a market cap of $775.15 million, a PE ratio of 41.90 and a beta of 0.82.

Insider Activity

In other Iradimed news, CFO John Glenn sold 2,500 shares of Iradimed stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $54.18, for a total value of $135,450.00. Following the transaction, the chief financial officer now owns 4,383 shares in the company, valued at $237,470.94. The trade was a 36.32 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 37.10% of the company’s stock.

Analysts Set New Price Targets

Separately, StockNews.com downgraded Iradimed from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, February 5th.

About Iradimed

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.